Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17Thoracic 2Gynecologic 2Genitourinary 2Dermatologic 2Head & Neck 1Breast 1

Conditions

Breast Neoplasms 40Triple Negative Breast Neoplasms 34Carcinoma, Non-Small-Cell Lung 28Melanoma 18Ovarian Neoplasms 16Carcinoma, Renal Cell 16Neoplasm Metastasis 13Pancreatic Neoplasms 12Carcinoma, Transitional Cell 12Colorectal Neoplasms 11Stomach Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Neoplasms 9Uterine Cervical Neoplasms 7Lung Neoplasms 7Head and Neck Neoplasms 7Endometrial Neoplasms 7Carcinoma, Merkel Cell 7Carcinoma, Hepatocellular 7Small Cell Lung Carcinoma 6Prostatic Neoplasms 6Gastrointestinal Neoplasms 5Sarcoma 4Mesothelioma 4Urinary Bladder Neoplasms 3Lymphoma 3Hodgkin Disease 3Esophageal Neoplasms 3Cholangiocarcinoma 3Carcinoma, Ovarian Epithelial 3

Interventions

spartalizumab 2durvalumab 2zanidatamab 1tremelimumab 1trastuzumab deruxtecan 1tislelizumab 1pembrolizumab 1obinutuzumab 1naptumomab estafenatox 1Trastuzumab 1Polymerase Chain Reaction 1Nivolumab 1Mass Spectrometry 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Gemcitabine 1Capecitabine 1Albumin-Bound Paclitaxel 1Ado-Trastuzumab Emtansine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Nivolumab × Breast × Clear all
NCT07334119 2026-05-20

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Myeloid Therapeutics

Phase 1 Recruiting
60 enrolled
BreastGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma Of Esophagus, Carcinoma, Ovarian Epithelial, Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡